Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Recruiting Not applicable

Metacognitive Bibliotherapy for Anxiety, Depression, and Metacognitions in University Students

NCT07627139 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2026-10-19
Last updated
2026-11-02

Condition(s) studied

AnxietyDepressionStress (Psychology)

Investigational drug(s) / intervention(s)

Zihninde Çok Kuran İnsanlar için Salma RehberiÇapa Atmak

Zihninde Çok Kuran İnsanlar için Salma Rehberi: Structured self-help book based on metacognitive therapy principles, targeting the Cognitive Attentional Syndrome (worry, rumination, threat monitoring and unhelpful coping strategies). Participants read the book at their own pace over 8 weeks without therapist contact. Reading progress is recorded with a weekly one-item online reading log.

Çapa Atmak: Self-help book read under the same conditions as Intervention 1: self-paced reading over 8 weeks without therapist contact, with a weekly one-item online reading log.

Study summary

This study tests whether reading a structured self-help book (bibliotherapy) can reduce anxiety, depression and stress and change unhelpful thinking patterns in medical and health-sciences students.

Students in health programs face heavy academic and clinical demands and are at increased risk of emotional distress. A thinking style called the Cognitive Attentional Syndrome (worry, rumination, threat monitoring and unhelpful coping) is thought to link stress to anxiety and depression. Metacognitive therapy targets this thinking style, and low-intensity self-help books may make these principles accessible to students.

A total of 165 students at İstanbul Nişantaşı University will be randomly assigned to one of three groups: two groups each receive a different self-help book and read it at their own pace over 8 weeks, and the third group (waitlist) receives the books after the study ends. All participants complete short online questionnaires (DASS-21, CAS-1, MCQ-30) at the start, at week 4 and at week 8, and receive brief telephone calls at weeks 2, 4 and 6 to confirm participation.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: * Age 18 years or older * Currently enrolled as a student in a medicine or health-sciences program (medicine, psychology, nursing and dentistry) at İstanbul Nişantaşı University * Sufficient proficiency in reading and understanding Turkish * Access to an internet-connected device to complete online forms * Electronic informed consent Exclusion Criteria: * Currently receiving active psychiatric treatment (psychotherapy or psychotropic medication) * Change in psychotropic medication within the last 6 months * Having previously read either of the study books * Diagnosis of bipolar disorder * Acute psychotic symptoms or current suicide risk

Primary outcome measure(s)

  • Change in Depression, Anxiety, and Stress Scales (DASS-21) total score — Baseline (week 0) to week 8
    DASS-21 (Turkish version), 21 items rated 0-3; total score is the sum of all items (range 0-63). Higher scores indicate greater psychological distress. Change from baseline to week 8 is compared between groups.

Trial sites (1)

FacilityCityRegionStatus
Istanbul Nişantaşı University Istanbul Sarıyer Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07627139 on ClinicalTrials.gov ↗ ← All trials in Turkey